Approach Considerations, Symptomatic Therapy/Supportive Care, Overview of Stepwise Therapy. World Gastroenterology Organisation (WGO). World Gastroenterology Organisation Global Guideline. Inflammatory bowel disease: a global perspective. Munich, Germany: World Gastroenterology Organisation (WGO); 2. American Gastroenterological Association medical position statement: perianal Crohn's disease. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Kiran RP, Nisar PJ, Church JM, Fazio VW. The role of primary surgical procedure in maintaining intestinal continuity for patients with Crohn's colitis. Agrawal D, Rukkannagari S, Kethu S. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease.
Minerva Gastroenterol Dietol. Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease: an overview. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, et al. Genome- wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Crohn's disease is an inflammation that extends into the deeper layers of the intestinal wall. It is found most often in the area bridging the small. Urology Test Procedures Surgical Positions Stumper Terms Surgery Suffixes Respiratory Report Phrases Report Headings Radiology Psychiatry Physical Exam Prefixes. In addition to treatment of the underlying inflammation, patients with inflammatory bowel disease (IBD) may require symptomatic.Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol. Inflammatory bowel disease. Cleveland Clinic: Current Clinical Medicine - - 2. Philadelphia, Pa: Saunders; 2. Wilkins T, Jarvis K, Patel J. Diagnosis and management of Crohn's disease. Trinchieri A, Lizzano R, Castelnuovo C, Zanetti G, Pisani E. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease. Arch Ital Urol Androl. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Jantchou P, Morois S, Clavel- Chapelon F, Boutron- Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3. N prospective study. Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH. Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring. Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease: an overview. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD 1. Crohn's disease: a cohort study. Hugot JP, Chamaillard M, Zouali H, Lesage S, C. Association of NOD2 leucine- rich repeat variants with susceptibility to Crohn's disease. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome- wide association study identifies IL2. R as an inflammatory bowel disease gene. Glas J, Seiderer J, Wetzke M, Konrad A, T. IL2. 3R Arg. 38. 1Gln is associated with childhood onset inflammatory bowel disease in Scotland. Genome- wide association defines more than 3. Crohn's disease. A genome- wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG1. L1. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Novel Crohn disease locus identified by genome- wide association maps to a gene desert on 5p. PTGER4. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Genome- wide association study of 1. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. ATG1. 6L1 and IL2. R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Silverberg MS, Cho JH, Rioux JD, Mc. Govern DP, Wu J, Annese V, et al. Ulcerative colitis- risk loci on chromosomes 1p. HLA- Cw*1. 20. 2- B*5. DRB1*1. 50. 2 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Centers for Disease Control and Prevention. Inflammatory bowel disease (IBD). Available at http: //www. IBD. Accessed: August 6, 2. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1. Crohn's disease in Olmsted County, Minnesota, 1. Roth MP, Petersen GM, Mc. Elree C, Feldman E, Rotter JI. Geographic origins of Jewish patients with inflammatory bowel disease. Sonnenberg A, Mc. Carty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Shivananda S, Lennard- Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC- IBD). Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol. Mortality in inflammatory bowel disease: a population- based cohort study. Jess T, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1. Mortality by medication use among patients with inflammatory bowel disease, 1. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta- analysis. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Available at http: //www. S0. 01. 6- 5. 08. Accessed: August 6, 2. Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas. London, UK: National Institute for Health and Clinical Excellence (NICE); 2. Available at http: //guideline. Accessed: August 6, 2. Barclay L. COPD, Asthma May Up Risk for Inflammatory Bowel Disease. Medscape Medical News. Available at http: //www. Accessed: November 2. Brassard P, Vutcovici M, Ernst P, Patenaude V, Sewitch M, Suissa S, et al. Increased incidence of inflammatory bowel disease in Qu. Brooks AJ, Rowse G, Ryder A, Peach EJ, Corfe BM, Lobo AJ. Systematic review: psychological morbidity in young people with inflammatory bowel disease - risk factors and impacts. Aliment Pharmacol Ther. Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold . Ulcerative colitis and clinical course: results of a 5- year population- based follow- up study (the IBSEN study). Solberg IC, Vatn MH, H. Clinical course in Crohn's disease: results of a Norwegian population- based ten- year follow- up study. Clin Gastroenterol Hepatol. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin- Biroulet L. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther. Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2. Gisbert JP, Mc. Nicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Study backs wider use of fecal calprotectin in pediatric IBD workup. Medscape Medical News. The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta- Analysis. Prideaux L, De Cruz P, Ng SC, Kamm MA. Serological antibodies in inflammatory bowel disease: a systematic review. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Paulsen SR, Huprich JE, Fletcher JG, Booya F, Young BM, Fidler JL, et al. CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 7. Assessment of appropriateness of indications for CT enterography in younger patients. Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, et al. Small- bowel imaging in Crohn's disease: a prospective, blinded, 4- way comparison trial. Wilkins T, Jarvis K, Patel J. Diagnosis and management of Crohn's disease. Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when? Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. OMOM capsule endoscopy in diagnosis of small bowel disease. J Zhejiang Univ Sci B. Clinical outcomes of double- balloon endoscopy for the diagnosis and treatment of small- intestinal diseases. Clin Gastroenterol Hepatol. Complications in and performance of double- balloon enteroscopy (DBE): results from a large prospective DBE database in Germany. Initial experience with double- balloon enteroscopy at a U. S. Gerson LB, Flodin JT, Miyabayashi K.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |